1
Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Analysis of Characteristics of Peripheral Arterial Ischemia in Premature Babies and Effects of Nitroglycerin Patch Application

Child Health Nursing Research 2020³â 26±Ç 4È£ p.434 ~ 444
KMID : 1102120200260040434
±èÁ¤Àº ( Kim Jeong-Eun ) - Catholic University Seoul St. Mary¡¯s Hospital Neonatal Intensive Care Unit

ÀÌÁø¿ø ( Lee Jin-Won ) - Catholic University Seoul St. Mary¡¯s Hospital Neonatal Intensive Care Unit
±èµ¿¿¬ ( Kim Dong-Yeon ) - Catholic University Seoul St. Mary¡¯s Hospital Hematology Intensive Care Unit

Abstract

Purpose: The aim of this retrospective study was to analyze the characteristics of peripheral arterial ischemia and tissue necrosis in premature babies, as well as the effects of nitroglycerin.

Methods: In total, 513 newborns were enrolled who were admitted to the neonatal intensive care unit with a gestational age of 34 weeks or younger. Data were collected on general personal and clinical information, peripheral arterial ischemia, and nitroglycerin patch application in the premature infants. The collected data were analyzed using the x2 test, t-test, Mann-Whitney U test, logistic regression.

Results: Thirty-six (7.0%) infants had peripheral arterial ischemia, while 477 (93.0%) infants did not. Lower gestational age (x2=35.97, p<.001), lower birth weight (x2=29.40, p<.001), lower blood pressure (x2=23.10, p<.001), and insertion of an umbilical artery catheter (p<.001) were significantly associated with the occurrence of peripheral arterial ischemia. Among the preterm infants in whom nitroglycerin patches were applied, 30 (83.3%) premature infants without necrosis improved without complications, 4 (11.1%) showed hypotension, and 2 (5.6%) showed skin damage.

Conclusion: Based on a review of our experiences with nitroglycerin patches, we recommend closely observing skin color and using nitroglycerin patches on the skin to help improve flow in premature infants with peripheral arterial ischemia.
KeyWords

Ischemia, Necrosis, Nitroglycerin, Therapeutic use, Transdermal patch
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed